Ascentage Pharma Group International AAPG
NASDAQ AAPG
$17.60 +0.24 (+1.38%)
As of: Sep 4, 2026 · 10:13 AM EDT

Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025)

Ascentage Pharma Group International (AAPG) posted quarterly Treasury Shares of $417479.1 for Q4 2025, up 37384.91% year-over-year from N/an in Q4 2024, and up 37384.91% quarter-over-quarter from $1113.7 in Q4 2024.

Analysis

Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025) Analysis & Trends

Ascentage Pharma Group International's Treasury Shares history runs 3 years deep, the most recent figure standing at $417479.1 for Q4 2025.

  • In Q4 2025, Treasury Shares rose 37384.91% year-over-year to $417479.1; the TTM figure through Dec 2025 stood at $417479.1 (up 37384.91% YoY), while the FY2025 annual figure was $423000.0, up 42200.0% from the prior year.
  • Treasury Shares for Q4 2025 stood at $417479.1, up from $1113.7 in the prior quarter.
  • The five-year high for Treasury Shares was $3.0 million in Q4 2023, with the low at $1113.7 in Q4 2024.
  • The 3-year median for Treasury Shares is $417479.1 (2025), against an average of $1.1 million.
  • The sharpest annual moves came in 2024 and 2025: Treasury Shares plunged 99.96% in 2024, then soared 37384.91% in 2025.
  • Ascentage Pharma Group International's Treasury Shares stood at $3.0 million in 2023, then slumped by 99.96% to $1113.7 in 2024, then jumped by 37384.91% to $417479.1 in 2025.
  • Business Quant data shows AAPG's Treasury Shares at $417479.1 in Q4 2025, $1113.7 in Q4 2024, and $3.0 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - 2.72 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Ascentage Pharma Group International 1.57 Bn 1.29 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -417,479.09
Dec 31, 2025 -417,479.09
Dec 31, 2024 -1,113.73
Dec 31, 2024 -1,113.73
Dec 31, 2023 -2.97 Mn
Dec 31, 2023 -2.97 Mn